The Evolving Role of CD8+CD28− Immunosenescent T Cells in Cancer Immunology
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Evolving Role of CD8+CD28− Immunosenescent T Cells in Cancer Immunology
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 11, Pages 2810
Publisher
MDPI AG
Online
2019-06-10
DOI
10.3390/ijms20112810
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor endothelial cells as a potential target of metronomic chemotherapy
- (2019) Ji Yoon Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Next Generation CAR T Cells for the Immunotherapy of High-Grade Glioma
- (2019) Christopher T. Petersen et al. Frontiers in Oncology
- Senolytics and senostatics as adjuvant tumour therapy
- (2019) Susan Short et al. EBioMedicine
- The Coincidence Between Increasing Age, Immunosuppression, and the Incidence of Patients With Glioblastoma
- (2019) Erik Ladomersky et al. Frontiers in Pharmacology
- T-cell senescence contributes to abnormal glucose homeostasis in humans and mice
- (2019) Hyon-Seung Yi et al. Cell Death & Disease
- Brain Tumor Microenvironment and Host State: Implications for Immunotherapy
- (2019) William Tomaszewski et al. CLINICAL CANCER RESEARCH
- Senolytic therapy alleviates Aβ-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer’s disease model
- (2019) Peisu Zhang et al. NATURE NEUROSCIENCE
- Overcoming Tumor-Induced Immune Suppression: From Relieving Inhibition to Providing Costimulation with T Cell Agonists
- (2018) Dana A. Emerson et al. BIODRUGS
- T Cell Dysfunction in Cancer
- (2018) Daniela S. Thommen et al. CANCER CELL
- Functions of NKG2D in CD8+ T cells: an opportunity for immunotherapy
- (2018) Kushal Prajapati et al. Cellular & Molecular Immunology
- CD8+CD28- T cells: not only age-related cells but a subset of regulatory T cells
- (2018) Xiaoyong Chen et al. Cellular & Molecular Immunology
- T-cell Dysfunction in Glioblastoma: Applying a New Framework
- (2018) Karolina I. Woroniecka et al. CLINICAL CANCER RESEARCH
- T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
- (2018) Karolina Woroniecka et al. CLINICAL CANCER RESEARCH
- The function and dysfunction of memory CD8+ T cells in tumor immunity
- (2018) James L. Reading et al. IMMUNOLOGICAL REVIEWS
- A high frequency of CD8+CD28- T-suppressor cells contributes to maintaining stable graft function and reducing immunosuppressant dosage after liver transplantation
- (2018) Lei Geng et al. International Journal of Medical Sciences
- T cell senescence and CAR-T cell exhaustion in hematological malignancies
- (2018) Dimitri Kasakovski et al. Journal of Hematology & Oncology
- Differential Expression of CD8+T Cell Cytotoxic Effector Molecules in Blood and Gastrointestinal Mucosa in HIV-1 Infection
- (2018) Brenna E. Kiniry et al. JOURNAL OF IMMUNOLOGY
- Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial
- (2018) Thomas Powles et al. LANCET
- Current state of immunotherapy for glioblastoma
- (2018) Michael Lim et al. Nature Reviews Clinical Oncology
- Multidimensional communication in the microenvirons of glioblastoma
- (2018) Marike L. Broekman et al. Nature Reviews Neurology
- Chimeric Antigen Receptor Therapy
- (2018) Carl H. June et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma
- (2018) Ayguen Sahin et al. PLoS One
- A non-conserved amino acid variant regulates differential signalling between human and mouse CD28
- (2018) Nicla Porciello et al. Nature Communications
- Regulatory T cells trigger effector T cell DNA damage and senescence caused by metabolic competition
- (2018) Xia Liu et al. Nature Communications
- Unwrapping the genomic characteristics of urothelial bladder cancer and successes with immune checkpoint blockade therapy
- (2018) Wen Cheng et al. Oncogenesis
- IL-10 inducible CD8+ regulatory T-cells are enriched in patients with multiple myeloma and impact the generation of antigen-specific T-cells
- (2018) Julian Plaumann et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Management of Brain Metastases in the New Era of Checkpoint Inhibition
- (2018) Adam Lauko et al. Current Neurology and Neuroscience Reports
- Senescence markers - predictive for response to checkpoint inhibitors?
- (2018) Alvaro Moreira et al. INTERNATIONAL JOURNAL OF CANCER
- In vivo fate and activity of second versus third-generation D19-specific CAR-T cells in B-cell non-Hodgkin lymphomas
- (2018) Carlos A. Ramos et al. MOLECULAR THERAPY
- Senescence and senotherapeutics: a new field in cancer therapy
- (2018) Vassilios Myrianthopoulos et al. PHARMACOLOGY & THERAPEUTICS
- Description of CD8+ Regulatory T Lymphocytes and Their Specific Intervention in Graft-versus-Host and Infectious Diseases, Autoimmunity, and Cancer
- (2018) Martha R. Vieyra-Lobato et al. Journal of Immunology Research
- CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
- (2018) Bagher Farhood et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Chronic Infections: A Possible Scenario for Autophagy and Senescence Cross-Talk
- (2018) Milton Aguilera et al. Cells
- Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients
- (2017) Dominique Farge et al. Journal of Hematology & Oncology
- The Clinical Potential of Senolytic Drugs
- (2017) James L. Kirkland et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Aptamers as targeted therapeutics: current potential and challenges
- (2017) Jiehua Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- Senescent cells: an emerging target for diseases of ageing
- (2017) Bennett G. Childs et al. NATURE REVIEWS DRUG DISCOVERY
- Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143
- (2017) Antonio Omuro et al. NEURO-ONCOLOGY
- OS10.3 Randomized Phase 3 Study Evaluating the Efficacy and Safety of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: CheckMate 143
- (2017) D. A. Reardon et al. NEURO-ONCOLOGY
- T Cell Exhaustion in Glioblastoma: Intricacies of Immune Checkpoints
- (2017) Reza Mirzaei et al. TRENDS IN IMMUNOLOGY
- Recurrent glioma clinical trial, CheckMate-143: the game is not over yet
- (2017) Anna C. Filley et al. Oncotarget
- HIV-Specific CD8 + T Cells Exhibit Reduced and Differentially Regulated Cytolytic Activity in Lymphoid Tissue
- (2017) Morgan A. Reuter et al. Cell Reports
- Membrane Rafts in T Cell Activation: A Spotlight on CD28 Costimulation
- (2017) Sara Zumerle et al. Frontiers in Immunology
- Divide, Conquer, and Sense: CD8+CD28− T Cells in Perspective
- (2017) Fernando A. Arosa et al. Frontiers in Immunology
- Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications
- (2017) Mariona Cabo et al. OncoImmunology
- Interleukin-21 administration to aged mice rejuvenates their peripheral T-cell pool by triggeringde novothymopoiesis
- (2016) E. Al-Chami et al. AGING CELL
- Robust, universal biomarker assay to detect senescent cells in biological specimens
- (2016) Konstantinos Evangelou et al. AGING CELL
- Targeting inhibition of Foxp3 by a CD28 2′-Fluro oligonucleotide aptamer conjugated to P60-peptide enhances active cancer immunotherapy
- (2016) Teresa Lozano et al. BIOMATERIALS
- Cancer immunotherapy: the beginning of the end of cancer?
- (2016) Sofia Farkona et al. BMC Medicine
- The Basis of Oncoimmunology
- (2016) A. Karolina Palucka et al. CELL
- Monitoring immune responses in the tumor microenvironment
- (2016) Jennifer A Wargo et al. CURRENT OPINION IN IMMUNOLOGY
- T Cell Cosignaling Molecules in Transplantation
- (2016) Mandy L. Ford IMMUNITY
- CD28 Costimulation: From Mechanism to Therapy
- (2016) Jonathan H. Esensten et al. IMMUNITY
- Co-stimulatory and Co-inhibitory Pathways in Autoimmunity
- (2016) Qianxia Zhang et al. IMMUNITY
- Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease
- (2016) John Attanasio et al. IMMUNITY
- Targeting T Cell Co-receptors for Cancer Therapy
- (2016) Margaret K. Callahan et al. IMMUNITY
- Belatacept and Long-Term Outcomes in Kidney Transplantation
- (2016) Flavio Vincenti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exploring and exploiting the systemic effects of deregulated replication licensing
- (2016) Theodoros G. Petrakis et al. SEMINARS IN CANCER BIOLOGY
- Reprogramming away from the exhausted T cell state
- (2016) Peter Karagiannis et al. SEMINARS IN IMMUNOLOGY
- T Cells Going Innate
- (2016) Midas Seyda et al. TRENDS IN IMMUNOLOGY
- MRP1-CD28 bi-specific oligonucleotide aptamers: target costimulation to drug-resistant melanoma cancer stem cells
- (2016) Mario Martínez Soldevilla et al. Oncotarget
- Third-generation CD28/4-1BB chimeric antigen receptor T cells for chemotherapy relapsed or refractory acute lymphoblastic leukaemia: a non-randomised, open-label phase I trial protocol
- (2016) Xiao-Yi Tang et al. BMJ Open
- Steroid Resistant CD8+CD28null NKT-Like Pro-inflammatory Cytotoxic Cells in Chronic Obstructive Pulmonary Disease
- (2016) Greg Hodge et al. Frontiers in Immunology
- The role of inflammation in age-related disease
- (2016) T. Kevin Howcroft et al. Aging-US
- Shifts in subsets of CD8+ T-cells as evidence of immunosenescence in patients with cancers affecting the lungs: an observational case-control study
- (2015) Oscar Okwudiri Onyema et al. BMC CANCER
- Low intratumoral regulatory T cells and high peritumoral CD8+ T cells relate to long-term survival in patients with pancreatic ductal adenocarcinoma after pancreatectomy
- (2015) Li Liu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma
- (2015) Elias J. Sayour et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- How Do Cytotoxic Lymphocytes Kill Cancer Cells?
- (2015) L. Martinez-Lostao et al. CLINICAL CANCER RESEARCH
- Adipocyte and leptin accumulation in tumor-induced thymic involution
- (2015) ALEJANDRO LAMAS et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Bioengineering Thymus Organoids to Restore Thymic Function and Induce Donor-Specific Immune Tolerance to Allografts
- (2015) Yong Fan et al. MOLECULAR THERAPY
- Immunosuppressive mechanisms in glioblastoma: Fig. 1.
- (2015) Edjah K. Nduom et al. NEURO-ONCOLOGY
- Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb
- (2015) Bettina Weigelin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
- (2015) David L. Porter et al. Science Translational Medicine
- Agonists of Co-stimulation in Cancer Immunotherapy Directed Against CD137, OX40, GITR, CD27, CD28, and ICOS
- (2015) Miguel F. Sanmamed et al. SEMINARS IN ONCOLOGY
- Differential regulation and function of tumor-infiltrating T cells in different stages of breast cancer patients
- (2015) Shiguang Zhu et al. TUMOR BIOLOGY
- CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome
- (2015) Yi Huang et al. Oncotarget
- The Role of Invariant Natural Killer T Cells in Dendritic Cell Licensing, Cross-Priming, and Memory CD8+ T Cell Generation
- (2015) Catherine Gottschalk et al. Frontiers in Immunology
- Poor survival in glioblastoma patients is associated with early signs of immunosenescence in the CD4 T-cell compartment after surgery
- (2015) Olesja Fornara et al. OncoImmunology
- Controlling T cell senescence in the tumor microenvironment for tumor immunotherapy
- (2015) Jian Ye et al. OncoImmunology
- Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial.
- (2015) Nabil Ahmed et al. Journal for ImmunoTherapy of Cancer
- Identification and Characterization of an Agonistic Aptamer Against the T Cell Costimulatory Receptor, OX40
- (2015) Elizabeth D. Pratico et al. Nucleic Acid Therapeutics
- CD28 Negative T Cells: Is Their Loss Our Gain?
- (2014) D. Mou et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Lymphocyte Subset Recovery and Outcome after Autologous Hematopoietic Stem Cell Transplantation for Plasma Cell Myeloma
- (2014) Jessica Rueff et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The intratumoural subsite and relation of CD8+ and FOXP3+ T lymphocytes in colorectal cancer provide important prognostic clues
- (2014) A Ling et al. BRITISH JOURNAL OF CANCER
- Downregulation of inhibitory SRC Homology 2 Domain-containing Phosphatase-1 (SHP-1) leads to recovery of T cell responses in elderly
- (2014) Aurélie Le Page et al. Cell Communication and Signaling
- An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
- (2014) Marco Demaria et al. DEVELOPMENTAL CELL
- TLR8 signaling enhances tumor immunity by preventing tumor-induced T-cell senescence
- (2014) J. Ye et al. EMBO Molecular Medicine
- Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy
- (2014) Xiaozhou Fan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Combined PD-1 blockade and GITR triggering induce a potent antitumor immunity in murine cancer models and synergizes with chemotherapeutic drugs
- (2014) Lei Lu et al. Journal of Translational Medicine
- The kinase p38 activated by the metabolic regulator AMPK and scaffold TAB1 drives the senescence of human T cells
- (2014) Alessio Lanna et al. NATURE IMMUNOLOGY
- Cellular senescence: from physiology to pathology
- (2014) Daniel Muñoz-Espín et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment
- (2013) Joel Crespo et al. CURRENT OPINION IN IMMUNOLOGY
- Changes of CD4+CD25+FOXP3+ and CD8+CD28− regulatory T cells in non-small cell lung cancer patients undergoing surgery
- (2013) Cheng Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Tumor-Derived Regulatory T Cells Suppress Innate and Adaptive Immunity through the Induction of Immunosenescence
- (2013) J. Ye et al. JOURNAL OF IMMUNOLOGY
- Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level
- (2013) Justyna Kmiecik et al. JOURNAL OF NEUROIMMUNOLOGY
- Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy
- (2013) Maria Themeli et al. NATURE BIOTECHNOLOGY
- The Ratios of CD8+ T Cells to CD4+CD25+ FOXP3+ and FOXP3- T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer
- (2013) Claudia C. Preston et al. PLoS One
- GITR Pathway Activation Abrogates Tumor Immune Suppression through Loss of Regulatory T-cell Lineage Stability
- (2013) D. A. Schaer et al. Cancer Immunology Research
- Postmitotic neurons develop a p21-dependent senescence-like phenotype driven by a DNA damage response
- (2012) Diana Jurk et al. AGING CELL
- Human regulatory T cells induce T-lymphocyte senescence
- (2012) J. Ye et al. BLOOD
- Telomere length and iPSC re-programming: survival of the longest
- (2012) Richard Allsopp CELL RESEARCH
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodeling
- (2012) S. Rajagopalan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New insights on the role of CD8+CD57+T-cells in cancer
- (2012) Richard C. Wu et al. OncoImmunology
- Effector T-Cell Infiltration Positively Impacts Survival of Glioblastoma Patients and Is Impaired by Tumor-Derived TGF-
- (2011) J. Lohr et al. CLINICAL CANCER RESEARCH
- Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family
- (2011) Hélène Bour-Jordan et al. IMMUNOLOGICAL REVIEWS
- CD8+ CD28− and CD8+ CD57+ T cells and their role in health and disease
- (2011) Marius Strioga et al. IMMUNOLOGY
- Cellular senescence and tumor suppressor gene p16
- (2011) Hani Rayess et al. INTERNATIONAL JOURNAL OF CANCER
- Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer
- (2011) Sahar M.A. Mahmoud et al. JOURNAL OF CLINICAL ONCOLOGY
- T cell exhaustion
- (2011) E John Wherry NATURE IMMUNOLOGY
- Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy
- (2010) David Coe et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients
- (2010) Zhi-Qing Yang et al. HUMAN IMMUNOLOGY
- Sustained CD28 Expression Delays Multiple Features of Replicative Senescence in Human CD8 T Lymphocytes
- (2010) Stanley T. Parish et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor-infiltrating lymphocytes, particularly the balance between CD8+ T cells and CCR4+ regulatory T cells, affect the survival of patients with oral squamous cell carcinoma
- (2010) Yoshiko Watanabe et al. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS
- CD28− T cells: their role in the age-associated decline of immune function
- (2009) Nan-ping Weng et al. TRENDS IN IMMUNOLOGY
- CD8+ T suppressor cells and the ILT3 master switch
- (2008) George Vlad et al. HUMAN IMMUNOLOGY
- CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer
- (2008) Rong-Fu Wang HUMAN IMMUNOLOGY
- Association of Graves’ Disease and Prevalence of Circulating IFN-γ-producing CD28− T Cells
- (2008) Zhiping Sun et al. JOURNAL OF CLINICAL IMMUNOLOGY
- CD8+CD28−, suppressive T cells in systemic lupus erythematosus
- (2008) A Tulunay et al. LUPUS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started